(Press-News.org) Researchers at Karolinska Institutet in Sweden have identified a new so-called pseudogene that regulates the tumour-suppressing PTEN gene. They hope that this pseudogene will be able to control PTEN to reverse the tumour process, make the cancer tumour more sensitive to chemotherapy and to prevent the development of resistance. The findings, which are published in the scientific journal Nature Structural and Molecular Biology, can be of significance in the future development of cancer drugs.
The development of tumours coincides with the activation of several cancer genes as well as the inactivation of other tumour-suppressing genes owing to damage to the DNA and to the fact that the cancer cells manage to switch off the transcription of tumour-suppressor genes. To identify what might be regulating this silencing, the researchers studied PTEN, one of the most commonly inactivated tumour-suppressor genes. It has long been believed that the switching-off process is irreversible, but the team has now shown that silenced PTEN genes in tumour cells can be 'rescued' and re-activated by a 'pseudogene', a type of gene that, unlike normal genes, does not encode an entire protein.
"We identified a new non-protein encoding pseudogene, which determines whether the expression of PTEN is to be switched on or off," says research team member Per Johnsson, doctoral student at Karolinska Institutet's Department of Oncology-Pathology. "What makes this case spectacular is that the gene only produces RNA, the protein's template. It is this RNA that, through a sequence of mechanisms, regulates PTEN. Pseudogenes have been known about for many years, but it was thought that they were only junk material."
No less than 98 per cent of human DNA consists of non-protein encoding genes (i.e. pseudogenes), and by studying these formerly neglected genes the researchers have begun to understand that they are very important and can have an effect without encoding proteins. Using model systems, the team has shown that the new pseudogene can control the expression of PTEN and make tumours more responsive to conventional chemotherapy.
"This means that we might one day be able to re-programme cancer cells to proliferate less, become more normal, and that resistance to chemotherapy can hopefully be avoided," says Per Johnsson. "We also believe that our findings can be very important for the future development of cancer drugs. What we're seeing here is just the tip of the iceberg. The human genome conceals no less than 15,000 or so pseudogenes, and it's not unreasonable to think that many of them are relevant to diseases such as cancer."
###
The study was conducted in collaboration with scientists at The Scripps Research Institute, USA, and the University of New South Wales, Australia, and was made possible with grants from the Swedish Childhood Cancer Foundation, the Swedish Cancer Society, the Cancer Research Funds of Radiumhemmet, Karolinska Institutet's KID programme for doctoral studies, the Swedish Research Council, the Erik and Edith Fernström Foundation for Medical Research, the National Institute of Allergy and Infectious Diseases, the National Cancer Institute and the National Institutes of Health.
Publication: 'A pseudogene long noncoding RNA network regulates PTEN transcription and translation in human cells', Per Johnsson, Amanda Ackley, Linda Vidarsdottir, Weng-Onn Lui, Martin Corcoran, Dan Grandér och Kevin V. Morris, Nature Structural and Molecular Biology, AOP 24 February 2013, doi: 10.1038/nsmb.2516. Embargoed until 24 February 2013 at 1800 London time / 1900 CET / 1300 US Eastern time.
For further information, please contact:
Dan Grandér, professor of experimental oncology
Department of Oncology-Pathology, Karolinska Institutet
Tel: +46 (0)8-517 762 62
Email: dan.grander@ki.se
Per Johnsson, doctoral student
Department of Oncology-Pathology, Karolinska Institutet
Tel: +46 (0)8-517 79 394
Email: per.a.johnsson@ki.se
Contact the Press Office and download photos: ki.se/pressroom
Karolinska Institutet – a medical university: ki.se/english
New type of gene that regulates tumor suppressor PTEN identified
2013-02-25
ELSE PRESS RELEASES FROM THIS DATE:
Asthma drug found highly effective in treating chronic, severe hives and itch
2013-02-25
An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash. The drug, omalizumab, was tested on 323 people at 55 medical centers for whom standard antihistamine therapy failed to quell their underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.
"Physicians and patients may now have a fast, safe and well-tolerated treatment option to consider before prescribing ...
Study: Babies born by C-section at risk of developing allergies
2013-02-25
DETROIT – For expectant moms who may contemplate the pros and cons of natural child birth or Caesarian section, a Henry Ford Hospital study suggests that C-section babies are susceptible to developing allergies by age two.
Researchers found that babies born by C-section are five times more likely to develop allergies than babies born naturally when exposed to high levels of common allergens in the home such as those from dogs, cats and dust mites.
The study is being presented Sunday at the American Academy of Allergy, Asthma and Immunology annual meeting in San Antonio.
"This ...
Scientists find surprising new influence on cancer genes
2013-02-25
LA JOLLA, CA – February 24, 2013 – Small stretches of DNA in the human genome are known as "pseudogenes" because, while their sequences are nearly identical to those of various genes, they have long been thought to be non-coding "junk" DNA.
But now, a new study led by scientists at The Scripps Research Institute (TSRI) shows how pseudogenes can regulate the activity of a cancer-related gene called PTEN. The study also shows that pseudogenes can be targeted to control PTEN's activity.
Published in the latest issue of the journal Nature Structural & Molecular Biology, ...
Taking the gamble out of DNA sequencing
2013-02-25
Two USC scientists have developed an algorithm that could help make DNA sequencing affordable enough for clinics – and could be useful to researchers of all stripes.
Andrew Smith, a computational biologist at the USC Dornsife College of Letters, Arts and Sciences, developed the algorithm along with USC graduate student Timothy Daley to help predict the value of sequencing more DNA, to be published in Nature Methods on February 24.
Extracting information from the DNA means deciding how much to sequence: sequencing too little and you may not get the answers you are looking ...
Ability of brain to protect itself from damage revealed
2013-02-25
The origin of an innate ability the brain has to protect itself from damage that occurs in stroke has been explained for the first time.
The Oxford University researchers hope that harnessing this inbuilt biological mechanism, identified in rats, could help in treating stroke and preventing other neurodegenerative diseases in the future.
'We have shown for the first time that the brain has mechanisms that it can use to protect itself and keep brain cells alive,' says Professor Alastair Buchan, Head of the Medical Sciences Division and Dean of the Medical School at Oxford ...
UN sustainable energy initiative could put world on a path to climate targets
2013-02-25
The new study in Nature Climate Change shows that reaching the 3 energy-related objectives proposed by the United Nations in their Sustainable Energy for All (SE4All) initiative, launched in 2011, would reduce emissions of greenhouse gases that contribute to climate change and, in combination with other measures, could help keep global temperature rise from exceeding the internationally agreed target level of 2°C.
"Achievement of the 3 objectives would provide an important entry point into stringent climate protection," says Joeri Rogelj, ETH Zurich researcher and IIASA-affiliated ...
Pain from the brain
2013-02-25
Psychogenic diseases, formerly known as 'hysterical' illnesses, can have many severe symptoms such as painful cramps or paralysis but without any physical explanation. However, new research from the University of Cambridge and UCL (University College London) suggests that individuals with psychogenic disease, that is to say physical illness that stems from emotional or mental stresses, do have brains that function differently. The research was published today, 25 February, in the journal Brain.
Psychogenic diseases may look very similar to illnesses caused by damage to ...
Laser mastery narrows down sources of superconductivity
2013-02-25
UPTON, NY – Identifying the mysterious mechanism underlying high-temperature superconductivity (HTS) remains one of the most important and tantalizing puzzles in physics. This remarkable phenomenon allows electric current to pass with perfect efficiency through materials chilled to subzero temperatures, and it may play an essential role in revolutionizing the entire electricity chain, from generation to transmission and grid-scale storage. Pinning down one of the possible explanations for HTS—fleeting fluctuations called charge-density waves (CDWs)—could help solve the ...
Researchers at IRB Barcelona discover a general mechanism that accelerates tumor development
2013-02-25
Cancer is characterized by uncontrolled cell division and growth. In order to identify new therapeutic targets through which to tackle the disease, scientists seek to clarify the mechanisms that control the expression of genes that favor the development of tumors, in processes such as uncontrolled cell division. Today, Nature has published a paper by the lab headed by Raúl Méndez, ICREA professor at the Institute for Research in Biomedicine (IRB Barcelona). The study describes a mechanism controlled by the CPEB1 protein that affects more than 200 genes related to cell proliferation ...
Fragments of continents hidden under lava in the Indian Ocean
2013-02-25
The islands Reunion and Mauritius, both well-known tourist destinations, are hiding a micro-continent, which has now been discovered. The continent fragment known as Mauritia detached about 60 million years ago while Madagascar and India drifted apart, and had been hidden under huge masses of lava. Such micro-continents in the oceans seem to occur more frequently than previously thought, says a study in the latest issue of Nature Geoscience ("A Precambrian microcontinent in the Indian Ocean," Nature Geoscience, Vol 6, doi: 10.1038/NGEO1736).
The break-up of continents ...